icad inc. (ICAD) News

icad inc. (ICAD): $3.82

0.01 (+0.26%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter ICAD News Items

ICAD News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

ICAD News Highlights

  • For ICAD, its 30 day story count is now at 7.
  • Over the past 22 days, the trend for ICAD's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • The most mentioned tickers in articles about ICAD are ACT, BEAT and ID.

Latest ICAD News From Around the Web

Below are the latest news stories about Icad Inc that investors may wish to consider to help them evaluate ICAD as an investment opportunity.

iCAD Q4 2021 Earnings Preview

iCAD (NASDAQ:ICAD) is scheduled to announce Q4 earnings results on Monday, February 28th, after market close. The consensus EPS Estimate is -$0.12 (-100.0% Y/Y) and the consensus Revenue Estimate is $7.82M (-25.5% Y/Y). Over the last 2 years, ICAD has beaten EPS estimates 38% of the time and has beaten...

Seeking Alpha | February 25, 2022

Analysts Estimate Icad (ICAD) to Report a Decline in Earnings: What to Look Out for

Icad (ICAD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | February 21, 2022

What Kind Of Shareholders Hold The Majority In iCAD, Inc.'s (NASDAQ:ICAD) Shares?

The big shareholder groups in iCAD, Inc. ( NASDAQ:ICAD ) have power over the company. Large companies usually have...

Yahoo | February 17, 2022

iCAD to Report Fourth Quarter and Full Year 2021 Financial Results on Monday, February 28

NASHUA, N.H., Feb. 14, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the fourth quarter and year ended December 31, 2021, after the market close, and host a conference call at 4:30 PM Eastern Time on Monday, February 28. Monday, February 28th at 4:30 PM ET Domestic:877-407-0784International:201-689-8560Conference ID:13726987Webcast:https

Yahoo | February 14, 2022

iCAD to Present at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

NASHUA, N.H., Feb. 08, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the Company will participate in the virtual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference from February 15-17, 2022. Stacey Stevens, President and incoming CEO of iCAD, is scheduled to participate in a fireside chat, hosted by research analyst Marie Thibault, on Tuesday, February 15, 2

Yahoo | February 8, 2022

Act Capital Management, Llc Buys Adtran Inc, Meta Platforms Inc, Vir Biotechnology Inc, Sells , ...

Investment company Act Capital Management, Llc (Current Portfolio) buys Adtran Inc, Meta Platforms Inc, Vir Biotechnology Inc, AirSculpt Technologies Inc, enVVeno Medical Corp, sells , Upstart Holdings Inc, Affirm Holdings Inc, Nektar Therapeutics, Nuance Communications Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Act Capital Management, Llc.

Yahoo | February 3, 2022

36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022

RALEIGH, NC / ACCESSWIRE / January 28, 2022 / The Winter Wonderland Best Ideas Virtual Investor Conference will take place on February 8th \- 11th, 2022, where 36 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience.The virtual conference begins on Tuesday, February 8th, 2022, with company presentations beginning at 8:30 am Eastern Time.

Yahoo | January 28, 2022

iCAD’s Breast AI Platform Earns U.S. Department of Defense Authorization to Operate

Leading-edge breast cancer detection platform meets stringent U.S. government security thresholds required for use across military healthcare facilitiesNASHUA, N.H., Jan. 24, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that the Company’s breast artificial intelligence (AI) platform was granted an Authorization to Operate (ATO) from the U.S. Department of Defense (DoD). iCAD’s b

Yahoo | January 24, 2022

Time To Worry? Analysts Are Downgrading Their iCAD, Inc. (NASDAQ:ICAD) Outlook

The analysts covering iCAD, Inc. ( NASDAQ:ICAD ) delivered a dose of negativity to shareholders today, by making a...

Yahoo | January 12, 2022

iCAD Announces the Appointment of New Members to its Board of Directors

Dana Brown and Timothy Norris Irish offer extensive experience in technology, women’s breast health and unique global perspectivesNASHUA, N.H., Jan. 11, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, announced today it has appointed Dana Brown and Timothy Norris Irish as new independent members of the Board of Directors, effective January 10, 2022. As previously announced, the Company also added

Yahoo | January 11, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8819 seconds.